Cancer is a disease characterized by unregulated cell growth due to genetic mutations.
It is not a single disease; rather, it encompasses a broad family of diseases that can manifest in any part of the body.
Definition: A disease caused by uncontrolled division of abnormal cells.
Typical prognosis without treatment is fatal due to:
Continuous cell proliferation disrupting normal cellular function.
Crowding out healthy cells.
Statistics:
In 2018, there were 18 million diagnoses and 9.6 million deaths globally.
Up to 50% of the population may develop cancer at some point in life.
Key characteristics shared by most cancers, originally summarised by Hanahan and Weinberg:
Self-sufficiency in growth signals.
Insensitivity to anti-growth signals.
Evading apoptosis.
Limitless replicative potential.
Sustained angiogenesis.
Tissue invasion and metastasis.
Updated (2011) to add:
Deregulated metabolism.
Evading the immune system.
Benign Tumours:
Small, slow-growing, non-invasive.
Well-differentiated and localized; cannot metastasize.
Malignant Tumours:
Large, fast-growing, invasive, and poorly-differentiated.
Capable of metastasizing and infiltrating adjacent tissues.
Normal cell division is controlled by signals from growth factor receptors; they undergo apoptosis when signaling ceases or DNA is damaged.
In cancer cells, mutations disrupt these controls, leading to uncontrolled growth:
They may proliferate without detecting neighboring cells.
They can produce their own growth signals and ignore apoptotic processes.
A cancer cell might take about 2.5 years to grow into a detectable grape-sized tumor, dividing approximately every 2-6 weeks.
Tumor size indicators:
1 million cells ≈ head of a pin.
1 billion cells ≈ small grape.
Invasion: Cancer cells spread from the primary site, needing changes to a migratory phenotype and using enzymes to degrade the extracellular matrix (ECM).
Metastasis: Tumor cells travel via the circulatory system to distant sites (commonly: bone, liver, brain, lungs, lymph nodes) forming secondary tumors.
Most cancer-related deaths are due to metastatic disease.
Tumors need oxygen and nutrients; lack of these can create a necrotic core within larger tumors.
Tumors secrete factors like VEGF to stimulate blood vessel growth (angiogenesis) towards them. This can be targeted with anti-angiogenic therapy.
The transformation of normal cells into cancer cells involves multiple genetic changes and can encompass:
Changes in cell morphology and behavior
Developments like hyperplasia and dysplasia
Formation of localized tumors termed "carcinoma in situ" which may progress to malignancy.
Oncogenes: Mutated forms of proto-oncogenes that promote cancer when activated (turned ON).
Tumor Suppressor Genes: Normal genes that, when inactivated (turned OFF), can lead to cancer by failing to control cell division or repair DNA damage.
Major genes include:
C-myc: transcription factor.
Ras: GTPase proteins.
P53: cell cycle regulator and apoptosis inducer.
BRCA1 & BRCA2: linked to breast and ovarian cancer.
Cancer may arise through two mutations:
Hereditary Tumors: One mutation inherited and one acquired.
Sporadic Tumors: Both mutations acquired.
Simultaneous mutations in oncogenes (p53 and Ras) can exacerbate cancer development through collaborative gene expression.
Lifestyle influences:
Smoking, obesity, poor diet, lack of exercise.
Environmental exposure:
UV radiation, air pollution, industrial chemicals.
Genetic predispositions related to family history.
Types:
Physical: Radiation exposure.
Chemical: Mutagens like benzopyrene or aflatoxins.
Biological: Viral and bacterial agents.
Viral: Can promote cancer via mechanisms such as degrading tumor suppressor genes or inducing chronic inflammation.
Notable viruses include HPV, HTLV, HBV, and Helicobacter pylori in stomach cancer.
Approximately 5-10% of cancers have hereditary components.
Indicators of hereditary linkage include:
Rare cancers, early onset cancers, multiple cancer types in individuals, familial patterns.
Examples of genes involved: APC (colon), BRCA1/2 (breast), MET (renal).